We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
-4.59%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
AUM
$54.4M
AUM Growth
-$33.4M
Cap. Flow
-$28.1M
Cap. Flow %
-51.73%
Top 10 Hldgs %
56.26%
Holding
47
New
Increased
Reduced
39
Closed
2

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 40.82%
2 Technology 35.37%
3 Financials 4.02%
4 Consumer Discretionary 3.19%
5 Industrials 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEO icon
1
NeoGenomics
NEO
$1.9B
$3.97M 7.3%
207,781
-119,657
-37% -$2.81M
PODD icon
2
Insulet
PODD
$11.4B
$3.95M 7.25%
23,934
-8,695
-27% -$1.22M
TWLO icon
3
Twilio
TWLO
$31.4B
$3.77M 6.92%
34,263
-14,781
-30% -$1.92M
CY
4
DELISTED
Cypress Semiconductor
CY
$3.72M 6.84%
159,460
-89,034
-36% -$2.04M
VCEL icon
5
Vericel Corp
VCEL
$2.38B
$3M 5.52%
198,445
-118,634
-37% -$2.08M
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.85M 5.23%
104,462
-57,680
-36% -$1.49M
UPLD icon
7
Upland Software
UPLD
$15.8M
$2.46M 4.52%
7,054
-4,007
-36% -$1.66M
FIVN icon
8
FIVE9
FIVN
$1.96B
$2.39M 4.38%
44,400
-26,214
-37% -$1.47M
CYBR
9
DELISTED
CyberArk
CYBR
$2.3M 4.23%
23,044
-14,339
-38% -$1.73M
OMCL icon
10
Omnicell
OMCL
$2.09B
$2.21M 4.07%
30,617
-17,811
-37% -$1.31M
ATRC icon
11
AtriCure
ATRC
$1.77B
$2.19M 4.02%
87,809
-46,887
-35% -$1.34M
MXL icon
12
MaxLinear
MXL
$6.43B
$2M 3.67%
89,316
-55,896
-38% -$1.24M
SUPN icon
13
Supernus Pharmaceuticals
SUPN
$2.79B
$1.36M 2.5%
49,462
-27,930
-36% -$828K
SPY icon
14
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.23M 2.26%
4,150
-300
-7% -$88.6K
SRGA
15
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$1.18M 2.18%
13,853
-10,227
-42% -$1.09M
CVLT icon
16
Commault Systems
CVLT
$6.12B
$1.16M 2.13%
25,962
-16,218
-38% -$743K
XENT
17
DELISTED
Intersect ENT, Inc
XENT
$1.15M 2.11%
67,390
-65,534
-49% -$1.19M
LGND icon
18
Ligand Pharmaceuticals
LGND
$6.08B
$1.05M 1.94%
16,957
-5,907
-26% -$371K
AAPL icon
19
Apple
AAPL
$4.9T
$1.01M 1.85%
17,976
PG icon
20
Procter & Gamble
PG
$349B
$671K 1.23%
5,394
-472
-8% -$55.8K
QQQ icon
21
Invesco QQQ Trust
QQQ
$466B
$647K 1.19%
3,425
AFL icon
22
Aflac
AFL
$63.5B
$622K 1.14%
11,895
-903
-7% -$47.7K
MAR icon
23
Marriott International
MAR
$96.6B
$608K 1.12%
4,888
-388
-7% -$51.5K
JPM icon
24
JPMorgan Chase
JPM
$907B
$594K 1.09%
5,049
-428
-8% -$48.4K
VTI icon
25
Vanguard Total Stock Market ETF
VTI
$658B
$574K 1.05%
3,800

Similar funds

Kopp Investment Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Kopp Investment Advisors held 47 positions worth $54.4M, down 38% from $87.8M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Kopp Investment Advisors withdrew a net $28.1M in Q3 2019, closing 2 positions and reducing 39 holdings. Its most notable exit was Finisar Corp, an estimated $2.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Technology and Financials.

  • Kopp Investment Advisors's biggest Q3 2019 reduction was NeoGenomics, cutting an estimated $2.81M.
  • Kopp Investment Advisors fully exited Finisar Corp in Q3 2019, selling an estimated $2.36M.
  • Kopp Investment Advisors's ten largest holdings make up 56% of its $54.4M portfolio in Q3 2019.
  • Kopp Investment Advisors opened 0 new positions and closed 2 in Q3 2019.
  • Kopp Investment Advisors's portfolio value fell 38% quarter-over-quarter to $54.4M.

Based on Kopp Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.